Fennec Pharmaceuticals Announces FDA Acceptance of New Drug Application Resubmission for PEDMARK™GlobeNewsWire • 06/22/21
Fennec Pharma Refiles Pedmark US Application For Cisplatin-Induced Ototoxicity In Pediatric PatientsBenzinga • 05/28/21
Fennec Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 05/13/21
Fennec Announces Fiscal Year 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 03/30/21
Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 11/16/20
FENC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 2, 2020 in the Class Action Filed on Behalf of Fennec Pharmaceuticals Inc. Limited ShareholdersNewsfile Corp • 11/02/20
FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fennec Pharmaceuticals Inc. Investors of the Important November 2 Deadline in Securities Class Action - FENCPRNewsWire • 11/02/20
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Fennec Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 2, 2020 - FENCNewsfile Corp • 11/02/20
FENC Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Fennec Pharmaceuticals Inc. Investors of Class Action and Lead Plaintiff Deadline: November 2, 2020Newsfile Corp • 11/02/20
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 11/02/20
FENC Final Deadline Alert: Rosen, Top Ranked Global Counsel, Reminds Fennec Pharmaceuticals Inc. Investors of the Important November 2 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - FENCNewsfile Corp • 10/30/20
FENC Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fennec Pharmaceuticals Inc. Investors of Class Action and Lead Plaintiff Deadline: November 2, 2020Business Wire • 10/30/20
DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 10/30/20
FENC CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files a Securities Fraud Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)PRNewsWire • 10/29/20
MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 10/29/20
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Fennec Pharmaceuticals, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 10/29/20
FINAL DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fennec Pharmaceuticals Inc. Investors of the Important November 2 Deadline in Securities Class Action - FENCPRNewsWire • 10/28/20
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)PRNewsWire • 10/28/20
MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 10/28/20
MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 10/27/20
ROSEN, A LEADING LAW FIRM, Reminds Fennec Pharmaceuticals Inc. Investors of the Important November 2 Deadline in Securities Class Action - FENCNewsfile Corp • 10/23/20
FENC SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fennec Pharmaceuticals Inc.PRNewsWire • 10/14/20
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fennec Pharmaceuticals Inc. Investors of the Important Deadline in Securities Class Action - FENCNewsfile Corp • 10/12/20
ROSEN, A TOP RANKED LAW FIRM, Reminds Fennec Pharmaceuticals Inc. Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - FENCPRNewsWire • 10/10/20
